DUBLIN--(BUSINESS WIRE)--The "Viral Vectors & Plasmid DNA Manufacturing Market Report 2024-2034" report has been added to ResearchAndMarkets.com's offering. Overall world revenue for the viral vectors ...
FARGO, N.D.--(BUSINESS WIRE)--Aldevron announced today the immediate availability of rep/cap plasmids pALD-AAV2, AAV5 and AAV6 to support AAV viral vector manufacturing. All three rep/cap plasmids are ...
WEST JEFFERSON, OH and GAITHERSBURG, MD / ACCESSWIRE / October 31, 2023 / AmplifyBio, a leading service provider for the commercialization of advanced modality therapeutics, and Vector BioMed, a ...
In the early 1990s, researchers set out to harness viruses for gene therapy applications. The idea was to co-opt a virus’ natural ability to target cells, transverse the membrane and deliver genetic ...
Off-the-shelf pHelper simplifies gene therapy supply chains with immediate availability WILMINGTON, Mass.--(BUSINESS WIRE)-- Charles River Laboratories International, Inc. (NYSE: CRL) today announced ...
Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of its off-the-shelf lentiviral vector (LVV) packaging plasmids, providing a streamlined solution to the ...
Furthermore, miniVec plasmids deliver significantly enhanced functionality in a wide range of in vitro and in vivo applications, including transient transfection, electroporation, virus packaging, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results